Dr. S. Indu Rupassara, Ph.D. - FruitVaccine - Fruit-Based Vaccines Against Globally Problematic Infectious Diseases episode artwork

EPISODE · May 2, 2023 · 54 MIN

Dr. S. Indu Rupassara, Ph.D. - FruitVaccine - Fruit-Based Vaccines Against Globally Problematic Infectious Diseases

from Progress, Potential, and Possibilities Podcast / Show · host Ira Pastor / Dr. S. Indu Rupassara

Send us Fan MailDr. S. Indu Rupassara, Ph.D., MBA is Co-Founder, President and CEO, of FruitVaccine ( http://www.fruitvaccine.org/ ), a company developing and manufacturing novel, safe and cost-effective fruit-based vaccines, with a goal of providing immunity against globally problematic infectious diseases. FruitVaccine's lead product is a vaccine which will immunize against the human respiratory syncytial virus (hRSV), a disease that all humans, especially infants and the elderly, are susceptible to, which effects the lower respiratory system and which no vaccine is available. Dr. Rupassara leads FruitVaccine overseeing its organizational, business, and R&D growth and is the Principal Investigator of FruitVaccine’s NSF-SBIR Grant Award, and has presented talks in conferences in the US, Europe, Australia, and Asia. Dr. Rupassara’s multidisciplinary expertise includes biotechnology, immunology, and ‘omics’ technologies, using an array of biological systems such as humans, animals, plants, and microorganisms. Dr. Rupassara received her PhD (Metabolomics/Biotechnology), MBA, and MS (Biochemistry) degrees from the University of Illinois at Urbana-Champaign, USA (UIUC), MSc (Microbiology) from the University of Sydney, Australia, and BSc (Agric. Sc.) from the University of Peradeniya, Sri Lanka. Support the show

Episode metadata supplied by the publisher feed · Published May 2, 2023

Embed this episode

Send us Fan Mail Dr. S. Indu Rupassara, Ph.D., MBA is Co-Founder, President and CEO, of FruitVaccine ( http://www.fruitvaccine.org/ ), a company developing and manufacturing novel, safe and cost-effective fruit-based vaccines, with a goal of providing immunity against globally problematic infectious diseases. FruitVaccine's lead product is a vaccine which will immunize against the human respiratory syncytial virus (hRSV), a disease that all humans, especially infants and the elderly, are susc...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dr. S. Indu Rupassara, Ph.D. - FruitVaccine - Fruit-Based Vaccines Against Globally Problematic Infectious Diseases

0:00 54:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Progress, Potential, and Possibilities Podcast / Show?

This episode is 54 minutes long.

When was this Progress, Potential, and Possibilities Podcast / Show episode published?

This episode was published on May 2, 2023.

Can I download this Progress, Potential, and Possibilities Podcast / Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!